BioProcess Blog |

​Join Dr. Howard L. Levine  (hlevinebptccom)  , President and Principal Consultant, at the Eight Annual BioProcess International European Conference, April 18-19, 2012 in Prague to learn more about manufacturing strategies for biologics, biosimilars and novel therapies. Drawing from BPTC’s proprietary Biopharmaceutical Product database and recently published report “The State of Mammalian Cell Culture Biomanufacturing,” Dr. Levine will speak on the “Global Demand and Utilization of Mammalian Cell Culture Manufacturing Capacity. His presentation will highlight the expected 50% growth in industry-wide capacity utilization between now and 2016 as well as the impact of recent technological advances in manufacturing processes, improvements in expression levels, widespread acceptance of single-use bioreactors, and the increased interest in biosimilars throughout the world. As with its sister event, the BioProcess International Conference held last October in Long Beach, CA, BPTC is pleased to be a part of BPI Europe. To pre-arrange a meeting with Dr. Levine at the conference, please click here  (hlevinebptccom)  .

Following on the heels of the annual BIO convention in the US, the BioProcess International Europe conference held in Vienna May 18-20 reinforced our optimism regarding the strength and continued growth of our industry. Attendance at the meeting was good with over 200 paid delegates participating in five concurrent tracks covering advances in upstream and downstream processing, scale-up strategies, formulation development, and analytical methods.

Read the rest of this entry »